AIMZ Investment Advisors LLC increased its stake in shares of Cigna Corp (NYSE:CI) by 44.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 11,665 shares of the health services provider’s stock after acquiring an additional 3,565 shares during the period. Cigna makes up approximately 1.7% of AIMZ Investment Advisors LLC’s holdings, making the stock its 20th largest holding. AIMZ Investment Advisors LLC’s holdings in Cigna were worth $2,215,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. raised its position in Cigna by 27.8% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 8,455 shares of the health services provider’s stock worth $1,761,000 after acquiring an additional 1,838 shares during the period. Commonwealth Equity Services LLC raised its position in Cigna by 8.6% in the third quarter. Commonwealth Equity Services LLC now owns 33,722 shares of the health services provider’s stock worth $7,022,000 after acquiring an additional 2,666 shares during the period. MML Investors Services LLC raised its position in Cigna by 25.1% in the third quarter. MML Investors Services LLC now owns 6,279 shares of the health services provider’s stock worth $1,308,000 after acquiring an additional 1,260 shares during the period. ClariVest Asset Management LLC raised its position in Cigna by 18.2% in the third quarter. ClariVest Asset Management LLC now owns 2,956 shares of the health services provider’s stock worth $614,000 after acquiring an additional 455 shares during the period. Finally, Commonwealth Bank of Australia raised its position in Cigna by 4.2% in the third quarter. Commonwealth Bank of Australia now owns 30,231 shares of the health services provider’s stock worth $6,288,000 after acquiring an additional 1,222 shares during the period. 93.44% of the stock is currently owned by hedge funds and other institutional investors.

Several research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Cigna from a “hold” rating to a “buy” rating and set a $208.00 price target on the stock in a research report on Friday, January 4th. ValuEngine upgraded shares of Cigna from a “sell” rating to a “hold” rating in a research report on Thursday, January 3rd. Credit Suisse Group reiterated a “buy” rating and issued a $250.00 price target on shares of Cigna in a research report on Monday, January 7th. Leerink Swann increased their price target on shares of Cigna from $250.00 to $260.00 and gave the stock an “outperform” rating in a research report on Monday, November 19th. Finally, Edward Jones assumed coverage on shares of Cigna in a research report on Monday, December 24th. They issued a “buy” rating and a $181.30 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have issued a buy rating to the company’s stock. Cigna has a consensus rating of “Buy” and a consensus target price of $231.28.

In related news, Director William D. Zollars sold 272 shares of the firm’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $168.43, for a total transaction of $45,812.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michael W. Triplett sold 9,148 shares of the firm’s stock in a transaction on Monday, February 11th. The shares were sold at an average price of $181.01, for a total transaction of $1,655,879.48. The disclosure for this sale can be found here. Over the last three months, insiders sold 10,420 shares of company stock valued at $1,886,122. Corporate insiders own 1.10% of the company’s stock.

Shares of NYSE CI opened at $166.45 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.42 and a quick ratio of 0.42. The firm has a market capitalization of $63.26 billion, a PE ratio of 11.71, a PEG ratio of 0.81 and a beta of 0.73. Cigna Corp has a 1 year low of $162.42 and a 1 year high of $226.60.

Cigna (NYSE:CI) last announced its quarterly earnings data on Friday, February 1st. The health services provider reported $2.46 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.53 by ($0.07). The firm had revenue of $13.75 billion during the quarter, compared to analysts’ expectations of $11.38 billion. Cigna had a return on equity of 16.64% and a net margin of 5.42%. The business’s revenue for the quarter was up 29.3% on a year-over-year basis. During the same period last year, the company earned $1.94 earnings per share. As a group, research analysts predict that Cigna Corp will post 16.41 earnings per share for the current fiscal year.

The company also recently disclosed a special dividend, which will be paid on Wednesday, April 10th. Stockholders of record on Monday, March 11th will be paid a $0.04 dividend. The ex-dividend date is Friday, March 8th. Cigna’s dividend payout ratio (DPR) is presently 0.28%.

TRADEMARK VIOLATION NOTICE: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.watchlistnews.com/aimz-investment-advisors-llc-buys-3565-shares-of-cigna-corp-ci/2896194.html.

Cigna Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Recommended Story: How Does the Quiet Period Work?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.